Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 5/20 | 0.55 |
| ▸ | CA2 | P00918 | 5/20 | 0.55 |
| ▸ | CA7 | P43166 | 4/20 | 0.55 |
| ▸ | CA9 | Q16790 | 4/20 | 0.38 |
| ▸ | CA4 | P22748 | 3/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28940629 | 0.92 | CA1 (0.47) | CA1CA2CA7CA9CA4 | |
| SCHEMBL28940742 | 0.92 | CA1 (0.47) | CA1CA2CA7CA9CA4 | |
| SCHEMBL28911492 | 0.89 | CA1 (0.45) | CA1CA2CA7CA9CA4 | |
| SCHEMBL28911646 | 0.89 | CA1 (0.45) | CA1CA2CA7CA9CA4 | |
| SCHEMBL5322671 | 0.84 | CA1 (0.59) | CA1CA2CA7CA9CA4 | |
| SCHEMBL497334 | 0.83 | CA1 (0.74) | CA1CA2CA7CA9CA4 | |
| SCHEMBL17390324 | 0.83 | TSHR (0.37) | — | |
| SCHEMBL28911560 | 0.81 | CA1 (0.52) | CA1CA2CA7CA9CA4 | |
| SCHEMBL28911526 | 0.81 | CA1 (0.35) | CA1CA2CA7 | |
| SCHEMBL7160070 | 0.81 | CA1 (0.71) | CA1CA2CA7CA9CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115466287-A | Halophosphite and preparation method and application thereof | 恒大新能源技术(深圳)有限公司 | 2022-12-13 | — | — | CN | disclosed |
| CN-115448945-A | Halogenated phosphate and preparation method and application thereof | 恒大新能源技术(深圳)有限公司 | 2022-12-09 | — | — | CN | disclosed |
| US-11220649-B2 | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium | SHOWA DENKO K.K. (JP) | 2022-01-11 | — | — | US | disclosed |
| EP-0503668-B1 | Alkenyl groups containing organosilicum compounds, a process for their preparation and their use | WACKER CHEMIE GMBH (DE) | 1996-01-17 | — | — | EP | disclosed |
| US-5250647-A | Reacting unsaturated ether with a triple bond and silicon compound having silicon-hydrogen bond; coatings, moldings | WACKER-CHEMIE GMBH | 1993-10-05 | — | — | US | disclosed |
| EP-0503668-A2 | Alkenyl groups containing organosilicum compounds, a process for their preparation and their use | WACKER-CHEMIE GMBH (DE) | 1992-09-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11220649-B2 | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium | AFF1, CHRM1, AFF2 | CA1 141/4885CA2 746/4885CA7 1939/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.